Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antigenics to Report Results on February 24, 2005; Conference Call to Follow.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Antigenics Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: AGEN) will release its fourth quarter and full-year 2004 financial results before the market opens on February 24, 2005.

Antigenics executives will host a conference call at 11:00 a.m. ET that same day. To access the live call, dial 888.271.9082 (domestic) or 706.679.7741 (international); the access code is 4078413. The call will also be web cast and will be accessible from the company's website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight ET on March 3, 2005. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 4078413. The replay will also be available on the company's website approximately two hours after the live call.

Antigenics is developing treatments for cancers, infectious diseases infectious diseases: see communicable diseases.  and autoimmune disorders Autoimmune Disorders Definition

Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction.
. For more information about Antigenics, please visit www.antigenics.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 17, 2005
Words:155
Previous Article:Xechem Announces Significant Progress in the Development of Its Sickle Cell Disease Drug NICOSAN/ HEMOXIN.
Next Article:Secured Services and Allegent Technology Group Announce U.S. Chamber of Commerce Deployment of Network Security Platform from Allegent.



Related Articles
Antigenics Announces Partial Clinical Hold on Phase III Trials for Kidney Cancer and Melanoma.
Antigenics Reports First Quarter 2004 Financial Results and Recent Highlights.
Antigenics Reports Third Quarter 2004 Financial Results and Recent Highlights.
Antigenics Reports Fourth Quarter and Year-End 2004 Financial Results and Highlights.
Antigenics to Report Results on May 5, 2005; Conference Call to Follow.
Antigenics Reports First Quarter 2005 Financial Results and Recent Highlights.
Antigenics to Report Fourth Quarter and Year-End 2005 Financial Results on February 23, 2006; Conference Call to Follow.
Antigenics Reports Third Quarter 2006 Financial Results.
Antigenics Reports Fourth Quarter and Year-End 2006 Financial Results.
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles